drugset / Trial / NCT05866029

Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture

NCT05866029

Recruiting 2478 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

This project anchors osteoporotic fractures, conduct registration and follow-up studies, and conduct prospective treatment studies. By registering for follow-up studies on osteoporotic fractures, it is planned to obtain epidemiological data through registration and follow-up studies; A prospective treatment study for patients with osteoporotic fractures is planned to explore effective treatment strategies through randomized controlled trials; To study biomarkers for osteoporotic refractures, we plan to establish a biomarker warning model through multi omics research; To study imaging biomarkers for osteoporotic refractures, a new imaging technology is proposed to establish an imaging omics warning model.

Timeline

Start
2023-05-26
Primary completion
2026-09-30
Completion
2026-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Denosumab Monoclonal antibody 60 mg Subcutaneous
Subject Teriparatide Protein / enzyme biologic 20 ug Subcutaneous

Indications